COVID-19 vaccines

Vial of the Johnson & Johnson coronavirus vaccine

After the Johnson & Johnson pause, enthusiasm for COVID-19 vaccines remains steady, U.S. survey shows

Despite high awareness of the temporary halt on the Johnson and Johnson vaccine, U.S. respondents remained eager to get vaccinated, according to a survey by researchers from Northeastern, Harvard, Northwestern, and Rutgers. But daily vaccination rates are declining nationally as those who most wanted the shots got them. A “hard core” group of respondents remain resistant.

by Peter Ramjug May 11, 2021

Everyone in the U.S. over the age of 16 is eligible to be vaccinated against COVID-19 as of April 19, 2021–a crucial step to bringing about the end of the pandemic. Photo by Ruby Wallau/Northeastern University

So you’re eligible for a COVID-19 vaccine. Now what?

Now that everyone in the U.S. over the age of 16 is eligible for COVID-19 vaccination, here’s how you can get your shots and do your part to protect the pack and support safety on campus and in the community.

by Eva Botkin-Kowacki April 18, 2021

A nurse prepares a dose of China's Sinopharm vaccine during a priority COVID-19 vaccination of health workers at a public hospital in Lima, Peru, on Feb. 10, 2021. Peru received its first shipment of COVID-19 vaccines on Sunday night. AP Photo by Martin Mejia

Will China’s global investment in ‘vaccine diplomacy’ pay off?

While the U.S. has been focused on curbing COVID-19 domestically, China, India, and other countries have been offering vaccines in hope of strengthening their alliances during the pandemic—a policy that carries risk, say three Northeastern professors.

by Ian Thomsen February 23, 2021

Boxes containing the Moderna COVID-19 vaccine are prepared to be shipped at the McKesson distribution center in Olive Branch, Miss., Sunday, Dec. 20, 2020. AP Photo by Paul Sancya, Pool

Here’s a 4-step plan to rescue the US vaccination program

The U.S. must create a national system for delivering and administering COVID-19 vaccinations, says Nada Sanders, distinguished professor of supply chain management at Northeastern.

by Ian Thomsen January 28, 2021

After the Johnson & Johnson pause, enthusiasm for COVID-19 vaccines remains steady, U.S. survey shows

So you’re eligible for a COVID-19 vaccine. Now what?

Will China’s global investment in ‘vaccine diplomacy’ pay off?

Here’s a 4-step plan to rescue the US vaccination program

Cookies on Northeastern sites